Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Cancer statistics, 2011
2011 Standout
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected Tumors
2005
Breast cancer
2019 Standout
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004–2013): Amassing data from independent Western populations provide etiologic clues
2017
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2007 Standout
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
2014
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Triple-Negative Breast Cancer
2010 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Breast cancer statistics, 2019
2019 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Mammographic Density and the Risk and Detection of Breast Cancer
2007 Standout
American Cancer Society Guidelines for the Early Detection of Cancer, 2006
2006
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
2012
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
2008 Standout
Cancer overdiagnosis: a biological challenge and clinical dilemma
2019
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Cancer Statistics, 2009
2009 Standout
Cancer Statistics, 2008
2008 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Breast Cancer Incidence, 1980 2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status
2007
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
Breast Density as a Predictor of Mammographic Detection: Comparison of Interval- and Screen-Detected Cancers
2000 Standout
Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all
2011
The molecular biology of head and neck cancer
2010 Standout
Consort 2010 statement: extension to cluster randomised trials
2012 Standout
American Cancer Society Guidelines for the Early Detection of Cancer, 2004
2004
Global cancer statistics
2011 Standout
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
American Cancer Society Guidelines for the Early Detection of Cancer, 2003
2003
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study
2004
A tense situation: forcing tumour progression
2009 Standout
Oesophageal carcinoma
2013 Standout
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
2005 Standout
Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence
2006
The Decrease in Breast-Cancer Incidence in 2003 in the United States
2007
Design and Analysis of Group-Randomized Trials in Cancer: A Review of Current Practices
2008
Constructive and unconstructive repetitive thought.
2008 Standout
Current and future burden of breast cancer: Global statistics for 2020 and 2040
2022 Standout
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
2003
Factors Contributing to Mammography Failure in Women Aged 40-49 Years
2004
Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations
2002 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
2005 Standout
Hepatocellular carcinoma
2022 Standout
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
2008 Standout
Cancer Statistics, 2010
2010 Standout
Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography
2003 Standout
Cancer statistics in China, 2015
2016 Standout
Estimates of Cancer Incidence in China for 2000 and Projections for 2005
2005
Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer
2008
Breast Cancer Treatment
2019 Standout
The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study
2018
Cancer statistics for the year 2020: An overview
2021 Standout
Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer
2009 Standout
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Global cancer statistics, 2012
2015 Standout
Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer
2018
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting
2006
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Divergent estrogen receptor‐positive and ‐negative breast cancer trends and etiologic heterogeneity in Denmark
2013
Works of MC Lin being referenced
Randomized Trial of Breast Self-Examination in Shanghai: Final Results
2002
Breast Tumor Characteristics as Predictors of Mammographic Detection: Comparison of Interval- and Screen-Detected Cancers
1999
53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer
2006